Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul-Aug;138(4):326-335.
doi: 10.1590/1516-3180.2019.0352.r2.15052020.

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review

Aloizio Premoli Maciel  1 , Reyna Aguilar Quispe  1 , Lázara Joyce Oliveira Martins  2 , Rogério Jardim Caldas  3 , Paulo Sérgio da Silva Santos  4
Affiliations
Review

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review

Aloizio Premoli Maciel et al. Sao Paulo Med J. 2020 Jul-Aug.

Abstract

Background: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is still the most prevalent type of osteonecrosis with clinical relevance. In Brazil, bisphosphonate use is high but there is a lack of epidemiological studies on BRONJ.

Objective: To determine the clinical profile of BRONJ in a Brazilian population through an integrative review.

Design and setting: Integrative review of BRONJ in a Brazilian population.

Methods: Cases and clinical research on Brazilians with BRONJ between 2010 and 2019, indexed in PubMed/MEDLINE, Scopus, Web of Science and LILACS were reviewed. Age, sex, type and time of bisphosphonate intake, administration route, related diseases, region of the BRONJ, diagnostic criteria, staging, triggering factor and type of treatment were analyzed.

Results: Fifteen articles on 128 subjects were included. Most patients were women (82.03%); the mean age was 63 years. Intravenous zoledronic acid was mostly used (62.50%), for breast cancer treatment (46.87%). The main localization of BRONJ was the mandible (54.68%), associated mainly with tooth extractions (45.98%). The diagnostic criteria were clinical (100%) and radiographic (89.06%), mostly in stage II (68.08%). The surgical treatments were sequestrectomy (37.50%) and platelet-rich plasma (PRP) (36.71%). Microbial control was done using chlorhexidine (93.75%) and infection control using clindamycin (53.90%).

Conclusions: BRONJ had higher prevalence in Brazilian women receiving treatment for breast cancer and osteoporosis. The mandible was the region most affected with a moderate stage of BRONJ, particularly when there were histories of tooth extraction and peri-implant surgery. Sequestrectomy with additional drugs and surgical therapy was the treatment most accomplished.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare that there was no conflict of interest

Figures

Figure 1.
Figure 1.. Flow diagram of the studies included in the integrative review
See this image and copyright information in PMC

References

    1. Drake MT, Clarke BL, Khosla SM. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83(9):1032–1045. doi: 10.4065/83.9.1032. - DOI - PMC - PubMed
    1. Duarte LF, Alonso K, Basso EC, Dib LL. Surgical treatment of bisphosphonate-related osteonecrosis of the jaws with the use of buccal fat pad: case report. Braz Dent J. 2015;26(3):317–320. doi: 10.1590/0103-6440201301918. - DOI - PubMed
    1. Miniello TG, Araújo JP, Lopes RN, Alves FA. Osteonecrosis related to once-yearly zoledronic acid treatment in an osteoporotic patient after dental implant. Braz Dent J. 2015;26(1):86–88. doi: 10.1590/0103-6440201300255. - DOI - PubMed
    1. Conte-Neto N, Bastos AS, Spolidorio LC, Marcantonio RA, Marcantonio E., Jr Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports. Head Face Med. 2011;7:7–7. doi: 10.1186/1746-160X-7-7. - DOI - PMC - PubMed
    1. Zanata A, Felin GC, De Bona MC, Sawazaki R, De Conto F. Osteonecrose mandibular associada ao uso de bisfosfonato de sódio em paciente com mieloma múltiplo [Bisphosphonate-related osteonecrosis of the jaw in patient affected by multiple myeloma: A case report] Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia Maxilofacial. 2014;55(2):115–120. doi: 10.1016/j.rpemd.2014.04.002. - DOI

MeSH terms

Substances